Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday after Morgan Stanley raised their price target on the stock from $100.00 to $120.00. Morgan Stanley currently has an overweight rating on the stock. Arrowhead Pharmaceuticals traded as high as $88.11 and last traded at […]

Investment analysts at Stifel Nicolaus initiated coverage on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Get Free Report) in a research report issued on Tuesday,Benzinga reports. The firm set a “buy” rating and a $98.00 price target on the biotechnology company’s stock. Stifel Nicolaus’ price objective would indicate a potential upside of 32.24% from the company’s […]